Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Olivennes

Showing results (41-50 of 115) with videos related to

Pageof 12
Sort By:
Human Reproduction (Oxford, England)|March 30, 2001
Tubal curettage: a new conservative treatment for haemorrhagic interstitial pregnanciesJ M Ayoubi, R Fanchin, F Olivennes, et al.
Human Reproduction Update|June 25, 2002
The use of GnRH antagonists in ovarian stimulationF Olivennes, J S Cunha-Filho, R Fanchin, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|March 29, 2002
[GnRH antagonists in IVF]F Olivennes, R Fanchin, N Lédée, et al.
Fertility and Sterility|February 1, 1997
Follow-up of a cohort of 422 children aged 6 to 13 years conceived by in vitro fertilizationF Olivennes, V Kerbrat, P Rufat, et al.
Fertility and Sterility|September 1, 1995
A new system for fallopian tube sperm perfusion leads to pregnancy rates twice as high as standard intrauterine inseminationR Fanchin, F Olivennes, C Righini, et al.
Human Reproduction (Oxford, England)|June 1, 1995
Scheduled administration of a gonadotrophin-releasing hormone antagonist (Cetrorelix) on day 8 of in-vitro fertilization cycles: a pilot studyF Olivennes, R Fanchin, P Bouchard, et al.
American Journal of Obstetrics and Gynecology|February 18, 1998
Female and male human embryo growth rates are similar before the eight-cell stageR Fanchin, C Righini, F Olivennes, et al.
Fertility and Sterility|July 1, 1996
Perinatal outcome of twin pregnancies obtained after in vitro fertilization: comparison with twin pregnancies obtained spontaneously or after ovarian stimulationF Olivennes, P Kadhel, P Rufat, et al.
Reproductive Biomedicine Online|July 2, 2003
Safety and efficacy of a 3 mg dose of the GnRH antagonist cetrorelix in preventing premature LH surges: report of two large multicentre, multinational, phase IIIb clinical experiencesF Olivennes, K Diedrich, R Frydman, et al.
Fertility and Sterility|September 1, 1993
Nonsurgical treatment of heterotopic pregnancy: a report of six casesH Fernandez, C Lelaidier, S Doumerc, et al.
Pageof 12

Showing results (41-50 of 115) with videos related to

Sort By:
Pageof 12
Human Reproduction (Oxford, England)|March 30, 2001
Tubal curettage: a new conservative treatment for haemorrhagic interstitial pregnanciesJ M Ayoubi, R Fanchin, F Olivennes, et al.
Human Reproduction Update|June 25, 2002
The use of GnRH antagonists in ovarian stimulationF Olivennes, J S Cunha-Filho, R Fanchin, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|March 29, 2002
[GnRH antagonists in IVF]F Olivennes, R Fanchin, N Lédée, et al.
Fertility and Sterility|February 1, 1997
Follow-up of a cohort of 422 children aged 6 to 13 years conceived by in vitro fertilizationF Olivennes, V Kerbrat, P Rufat, et al.
Fertility and Sterility|September 1, 1995
A new system for fallopian tube sperm perfusion leads to pregnancy rates twice as high as standard intrauterine inseminationR Fanchin, F Olivennes, C Righini, et al.
Human Reproduction (Oxford, England)|June 1, 1995
Scheduled administration of a gonadotrophin-releasing hormone antagonist (Cetrorelix) on day 8 of in-vitro fertilization cycles: a pilot studyF Olivennes, R Fanchin, P Bouchard, et al.
American Journal of Obstetrics and Gynecology|February 18, 1998
Female and male human embryo growth rates are similar before the eight-cell stageR Fanchin, C Righini, F Olivennes, et al.
Fertility and Sterility|July 1, 1996
Perinatal outcome of twin pregnancies obtained after in vitro fertilization: comparison with twin pregnancies obtained spontaneously or after ovarian stimulationF Olivennes, P Kadhel, P Rufat, et al.
Reproductive Biomedicine Online|July 2, 2003
Safety and efficacy of a 3 mg dose of the GnRH antagonist cetrorelix in preventing premature LH surges: report of two large multicentre, multinational, phase IIIb clinical experiencesF Olivennes, K Diedrich, R Frydman, et al.
Fertility and Sterility|September 1, 1993
Nonsurgical treatment of heterotopic pregnancy: a report of six casesH Fernandez, C Lelaidier, S Doumerc, et al.
Pageof 12